
    
      The study is to commence on May 1st 2015 and is to be completed within 3-5 years. The
      targeted number of patients to be enrolled is 8,000. All patients have the history of
      cardiovascular diseases, will be eligible to be enrolled. Patients inclusion criteria are as
      follows, once informed consent is obtained:

        1. Males or females at least 18 years old.

        2. Patient has not been previously enrolled in the molecular biological bank registry of
           the Fujian provincial hospital.

        3. Patient able to give informed consent.

        4. Any patient with history of cardiovascular diseases (If a subject reports history of
           cardiovascular diseases at another facility, outside records will be obtained to confirm
           the diagnosis.
    
  